No four consecutive quarters could be summed for EPS (Diluted), Interest Expense; these figures use the latest fiscal year, not a trailing twelve months.
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
No metric cleared the monthly-observation floor for this name — the archive covers 4,673 of the universe's names and reconstructs the per-share tier for US 10-K filers only.
P/E — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
ROE — only 4 monthly observations — under the 12-month floor for a series line.
ROIC — no reconstructed observations for this name and metric.
Net Margin — no reconstructed observations for this name and metric.
12M Momentum — no reconstructed observations for this name and metric.
EPS Growth 3Y — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Sales Growth 3Y — no reconstructed observations for this name and metric.
Market Cap — not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
▸Comp setname your own peers — pick a pool or add tickers
vs Health Care· 1053 names
Compared against all 1053 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
Metric
This (FY)
Peer median
IQR (25–75)
%ile
ROE
-198.2%
-36.9%
-92.5%–4.5%
9 ↓weak
Peers missing a metric are excluded from that metric's pool.
